IDO1 INHIBITOR EPACADOSTAT PROMOTES ANTI-TUMOR IMMUNITY IN RADIATED COLORECTAL CANCER MODEL

被引：0
|
作者：
Chen, Baosheng
Alvarado, David M.
Santhanam, Srikanth
Iticovici, Micah
Thotala, Dinesh
Ciorba, Matthew A.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1990
引用
收藏
页码：S874 / S874
页数：1
相关论文
共 50 条
  • [41] Determination of epacadostat, a novel IDO1 inhibitor in mouse plasma by LC-MS/MS and its application to a pharmacokinetic study in mice
    Dhiman, Vinay
    Giri, Kalpesh Kumar
    Suresh, P. S.
    Zainuddin, Mohd
    Rajagopal, Sriram
    Mullangi, Ramesh
    BIOMEDICAL CHROMATOGRAPHY, 2017, 31 (02)
  • [42] Potential Underprediction of Warfarin Drug Interaction From Conventional Interaction Studies and Risk Mitigation: A Case Study With Epacadostat, an IDO1 Inhibitor
    Shi, Jack G.
    Chen, Xuejun
    Punwani, Naresh G.
    Williams, William V.
    Yeleswaram, Swamy
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (11): : 1344 - 1354
  • [43] Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma
    Wu, Rui-Yan
    Kong, Peng-Fei
    Xia, Liang-Ping
    Huang, Yun
    Li, Zhi-Ling
    Tang, Yun-Yun
    Chen, Yu-Hong
    Li, Xuan
    Senthilkumar, Ravichandran
    Zhang, Hai-Liang
    Sun, Ting
    Xu, Xue-Lian
    Yu, Yan
    Mai, Jia
    Peng, Xiao-Dan
    Yang, Dong
    Zhou, Li-Huan
    Feng, Gong-Kan
    Deng, Rong
    Zhu, Xiao-Feng
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4530 - 4541
  • [44] Targeting SAMHD1 Promotes Anti-Tumor Immunity in Acute Myeloid Leukemia
    Zhang, Lei
    Dong, Haojie
    He, Xin
    Lin, Yichun
    Hu, Weidong
    Salhotra, Amandeep
    Armenian, Saro H.
    Marcucci, Guido
    Luo, Yun
    Li, Ling
    BLOOD, 2022, 140
  • [45] A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) AND EPACADOSTAT (IDO1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295
    Butt, Abeer
    Luo, Jingqin
    Tao, Yu
    Butt, Omar
    Etter, Kelsey
    Nehring, Leslie
    Hissim, Deanna
    Mckean, Cole
    Ansstas, George
    Kim, Albert
    Abraham, Christopher
    Kizilbash, Sani
    Strowd, Roy
    Johanns, Tanner
    Huang, Jiayi
    Ciorba, Matthew
    Campian, Jian
    Chheda, Milan
    NEURO-ONCOLOGY, 2024, 26
  • [46] Anti-tumor mechanisms of rigosertib in colorectal cancer
    Mehr, S. M. Hassanian
    Rahmani, F.
    Hashemzehi, M.
    Avan, A.
    Barneh, F.
    Asgharzadeh, F.
    Moradi-Marjaneh, R.
    Soleimani, A.
    Parizadeh, M.
    Ferns, G. A.
    Mobarhan, M. Ghayour
    Ryzhikov, M.
    Afshari, A. R.
    Ahmadian, M. R.
    Giovannetti, E.
    Jafari, M.
    Rezaei, A. R.
    Khazaei, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S441 - S441
  • [47] KHSRP promotes cancer stem cell maintenance, tumorigenesis, and suppresses anti-tumor immunity in gastric cancer
    Du, Yaru
    Pei, Zhihui
    Hu, Shuqin
    Liao, Chuanwen
    Liu, Shuhao
    ONCOLOGY RESEARCH, 2025, 33 (02) : 309 - 325
  • [48] Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice
    Zhang, Rongjie
    Wang, Yuanfeiyi
    Liu, Dan
    Luo, Qing
    Du, Peixin
    Zhang, Haiyan
    Wu, Wenshuang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [49] Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer
    Agarwal, Ekta
    Chaudhuri, Anathbandhu
    Leiphrakpam, Premila D.
    Haferbier, Katie L.
    Brattain, Michael G.
    Chowdhury, Sanjib
    BMC CANCER, 2014, 14
  • [50] Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells
    Rossini, Sofia
    Ambrosino, Sara
    Volpi, Claudia
    Belladonna, Maria Laura
    Pallotta, Maria Teresa
    Panfili, Eleonora
    Suvieri, Chiara
    Macchiarulo, Antonio
    Mondanelli, Giada
    Orabona, Ciriana
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345